“…It was reported also that a large number of quinolines and their derivatives possessed potent anticancer activity (Chen et al, 2005a(Chen et al, , b, 2006Zhao et al, 2005;Li et al, 2006;Tseng et al, 2008Tseng et al, , 2012Al-Said et al, 2011;Luniewski et al 2012;Karthikeyan et al, 2015). Several studies supported that the pyrimidine nucleus is an important pharmacophore in various antitumor agents (Ghorab et al, 1996(Ghorab et al, , 2006aGhorab, 2000;Abou El Ella et al, 2008;Liu et al, 2014;Shao et al, 2014;Kandeel et al, 2015;Ma et al, 2015). Moreover, it is present in potent marketed anticancer drugs, for example, gefitinib (Iressa TM ) (Wakeling et al, 2002) and erlotinib (Tarceva TM ) (Moyer et al, 1997), and thus, it is considered as attractive target for the design of new anticancer agents.…”